… Call Transcript March 27, 2024 DURECT Corporation beats earnings expectations. Reported EPS … nutritional support, as well as antibiotics for infection. In total, we … &A Session Follow Durect Corp (NASDAQ:DRRX) Follow Durect Corp (NASDAQ:DRRX) We …

DURECT Corporation (NASDAQ:DRRX) Q2 2019 Results … Arenberg, Chief Financial Officer of DURECT Corporation. I will provide a brief … time you were prescribed an antibiotic to be taken multiple times …

… approval of Merck's antibiotic; Durect's upcoming regulatory … 8.31% to $19.32. DURECT Corporation's (DRRX) full response … - Imipenem, a beta-lactam antibiotic; Cilastatin, a DHP-I inhibitor …

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 6) Bio-Rad Laboratories, Inc. (NYSE: BIO) BIO-TECHNE Corp (NASDAQ: TECH) CAS Medical Systems Inc (NASDAQ: CASM) …

… should universal administration of prophylactic antibiotics be used in hospitalized patients … trial of DUR-928 for Durect Corp. Please see the guidelines for …

… deliver several drugs such as antibiotics, anti-cancer agents, and anti … Shenzhen Polymtek Biomaterials Co. Ltd. Durect Corporation Key Takeaways of Market Report …

… polysaccharides, nutrients, chemotherapeutic agents, antibiotics, and vaccines are some … Ajinomoto Co. Inc., CertisUsa, Durect Corp., Earthrise NutritionalsLlc, Energy Derived, … Polysaccharides Nutrients Chemotherapeutic Agents Antibiotics Vaccines By End …

… with chronic hepatitis B (Saturday) DURECT Corporation (NASDAQ: DRRX): Phase 1b data … developing a new class of antibiotics for infections caused by bacteria …

… Pipeline Analysis 4.6.1 Durect Corporation/Sandoz's Posimir … in Fibromyalgia 6.3.7 Antibiotics Used in Fibromyalgia 6.4 … Sankyo Company Ltd. 15.13 Durect Corporation 15.14 Egalet Corporation 15 …

… Negative FDA Panel Vote Company: DURECT Corporation (NASDAQ: DRRX) and Pain Therapeutics … cream. Tetraphase Seeks Approval For Antibiotic to Treat Abdominal Infections Company …